2026-04-17T07:41:19Zhttps://recercat.cat/oai/requestoai:recercat.cat:10230/464482025-12-23T20:53:32Zcom_2072_6col_2072_452954
RECERCAT
author
Garriga Ferrer, Martina
2021-02-11T12:44:48Z2021-02-11T12:44:48Z2020-07
Treball de fi de grau en BiomèdicaTutor: Pilar Rivera GilPharmaceutical industry is one of the most relevant activities and plays a major role in
economics and the provision of global health. It is known that the processes of developing
new compounds and its entry to the market are very complex and require specific
guidelines that can only be provided by business and regulatory analytics. Although the
key players in such industry are big companies, drug development is becoming a
cooperative effort encouraging technology transfer since many compounds have their
discovery origins in academia and small innovative companies, such as spin-offs.
In this thesis, a business plan of the nanotechnological platform Nanotarg is presented.
This technology, whose origin arises from academic research in Universitat Pompeu
Fabra, enables specific targeting to tumoral tissue in the pancreas and can potentially
release the therapeutic gold standard to increase the survival rate of pancreatic cancer
patients.
The goal of this project is to provide clear strategy lines for those researchers aiming to
start the path of entrepreneurship. These business strategies derive from the exhaustive
analysis of different features that affect pharmaceutical business development, among
others, opportunity and market analysis are performed, as well as the SWOT and PESTEL
analysis and financial projections to ensure profits and revenues.
Atribución-NoComercial-SinDerivadas 3.0 España http://creativecommons.org/licenses/by-nc-nd/3.0/es/ info:eu-repo/semantics/openAccess
Entrepreneurship
Spin-off
Nanotechnological platform
Specific targeting
Pancreatic cancer
Business plan of Nanotarg: a technological platform aiming to treat pancreatic cancer
info:eu-repo/semantics/bachelorThesis